These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The biosimilar Ustekinumab has been developed and manufactured by the company
ICMR will continue to track trends in HMPV circulation throughout the year
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
The order, part of an international framework agreement is to be executed between February to April, 2025
The acquired hospital is a well-established hospital based out of Model Town, New Delhi
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
Subscribe To Our Newsletter & Stay Updated
